From: Intranasal administration with recombinant vaccine PRVXJ-delgE/gI/TK-S induces strong intestinal mucosal immune responses against PDCoV
Group
Vaccines for immunization
The challenged virus
A
2mL rPRVXJ-delgE/gI/TK-S
PRV
B
PDCoV
C
2mL rPRVXJ-delgE/gI/TK-EGFP
D
E
2mL DMEM
F